ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1211

$1.77M Total Retail Price of All Prescriptions

Rank: 6 out of 1211

996 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 996 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 31,914 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,689 1,579 1 1
OMEPRAZOLE 1,273 1,226 2 20
AMLODIPINE BESYLATE 972 919 3 2
ATENOLOL 787 733 4 13
METOPROLOL TARTRATE 767 723 5 4
IBUPROFEN 766 725 6 70
LOSARTAN POTASSIUM 693 641 7 12
ATORVASTATIN CALCIUM 692 607 8 9
LEVOTHYROXINE SODIUM 632 584 9 22
CRESTOR 594 557 10 11
TEMAZEPAM 563 549 11 73
LISINOPRIL 536 512 12 6
CLOPIDOGREL 529 503 13 10
METFORMIN HCL 526 473 14 27
DIOVAN 508 495 15 21
DIOVAN HCT 505 464 16 35
ALPRAZOLAM 473 468 17 54
JANUVIA 457 423 18 104
LOVASTATIN 422 418 19 37
PLAVIX 420 406 20 14
LOSARTAN-HYDROCHLOROTHIAZIDE 418 366 21 29
TAMSULOSIN HCL 417 403 22 62
RANITIDINE HCL 417 409 22 45
GLYBURIDE-METFORMIN HCL 392 363 R 24 111
CITALOPRAM HBR 386 381 25 67
METOPROLOL SUCCINATE 372 350 26 5
CLONIDINE HCL 372 358 26 34
FUROSEMIDE 351 315 28 7
DIGOXIN 351 310 28 15
MELOXICAM 342 307 30 88
ALENDRONATE SODIUM 340 331 31 60
HYDROCHLOROTHIAZIDE 340 305 31 17
NEXIUM 326 280 33 41
ALLOPURINOL 310 283 34 59
DONEPEZIL HCL 306 306 35 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 305 288 36 39
WARFARIN SODIUM 296 268 37 8
CARVEDILOL 275 245 38 3
AZITHROMYCIN 265 248 39 63
ISOSORBIDE MONONITRATE ER 243 239 40 16
ZOLPIDEM TARTRATE 242 193 41 32
ADVAIR DISKUS 242 232 41 84
POTASSIUM CHLORIDE 236 216 43 19
ACEBUTOLOL HCL 234 234 10 44 189
FLUTICASONE PROPIONATE 233 206 45 98
GABAPENTIN 231 198 46 57
PAROXETINE HCL 224 199 47 99
GLIPIZIDE 216 206 48 94
MECLIZINE HCL 210 202 49 90
TRAMADOL HCL 209 189 50 65
ENALAPRIL MALEATE 202 182 51 28
CLOTRIMAZOLE-BETAMETHASONE 193 192 52 116
AMOX TR-POTASSIUM CLAVULANATE 187 166 53 193
PANTOPRAZOLE SODIUM 181 166 54 44
PREDNISONE 168 165 55 100
FENOFIBRATE 167 163 56 42
BENICAR HCT 166 166 57 78
CELEBREX 159 157 58 124
MEGESTROL ACETATE 150 150 R 59 128
MOMETASONE FUROATE 146 137 60 266
CIPROFLOXACIN HCL 143 130 61 108
GLYBURIDE 140 139 R 62 109
GLIMEPIRIDE 139 128 63 101
NAPROXEN 138 121 64 120
VOLTAREN 136 130 65 106
VIAGRA 136 125 65 121
BENICAR 135 129 67 69
SYNTHROID 126 104 68 64
SINGULAIR 124 112 69 102
LACTULOSE 122 116 70 155
NITROSTAT 121 119 71 26
ESCITALOPRAM OXALATE 118 104 72 89
SOTALOL 117 117 73 33
LIPITOR 114 101 74 38
GEMFIBROZIL 113 103 75 134
DOXAZOSIN MESYLATE 111 101 76 48
AMLODIPINE BESYLATE-BENAZEPRIL 111 111 76 46
AMIODARONE HCL 108 95 78 30
ACTONEL 108 108 78 160
PENTOXIFYLLINE 106 105 80 152
LEXAPRO 103 97 81 138
LANTUS SOLOSTAR 103 103 81 214
CLORAZEPATE DIPOTASSIUM 102 101 83 163
FOLIC ACID 101 92 84 150
ACETAMINOPHEN-CODEINE 98 85 S3 85 169
DICLOFENAC SODIUM 96 74 86 117
METHYLPREDNISOLONE 95 81 87 184
SULINDAC 91 85 88 266
MUPIROCIN 91 89 88 168
NIFEDICAL XL 90 90 90 113
LANSOPRAZOLE 89 88 91 127
LABETALOL HCL 88 76 92 79
VALSARTAN-HYDROCHLOROTHIAZIDE 87 84 93 182
LORAZEPAM 87 82 93 115
SERTRALINE HCL 87 59 93 74
LYRICA 87 72 93 144
SPIRIVA 86 83 97 151
PRADAXA 86 86 97 23
LIDODERM 86 79 97 103
CIALIS 86 80 97 219
AVODART 83 83 101 166
NIFEDIPINE ER 83 80 101 43
BUMETANIDE 82 77 103 71
NEOMYCIN-POLYMYXIN-HC 79 70 104 299
PROPRANOLOL HCL 75 75 105 131
CLONAZEPAM 74 74 106 188
NAMENDA 74 74 106 80
FLOVENT HFA 74 67 106 278
TRICOR 73 70 109 82
ENALAPRIL-HYDROCHLOROTHIAZIDE 72 64 110 309
KETOCONAZOLE 72 68 110 136
DICYCLOMINE HCL 69 68 112 158
CYMBALTA 66 66 113 160
AMITRIPTYLINE HCL 66 61 R 113 170
INSULIN SYRINGE 64 47 115 126
TERAZOSIN HCL 64 64 115 141
COLCRYS 64 51 115 324
JANUMET 64 64 115 171
PROAIR HFA 64 63 115 125
CLOBETASOL PROPIONATE 61 61 120 234
CARBIDOPA-LEVODOPA 57 57 121 210
TEKTURNA 57 57 121 162
MONTELUKAST SODIUM 56 52 123 158
NYSTATIN-TRIAMCINOLONE 56 56 123 276
CARTIA XT 54 54 125 76
BYSTOLIC 53 49 126 36
FAMOTIDINE 52 52 127 66
QUETIAPINE FUMARATE 51 51 128 175
CYCLOBENZAPRINE HCL 51 44 R 128 173
EXFORGE 51 47 128 87
JANTOVEN 50 50 131 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.